Latest News

COVID-19 – FDA approves hydroxychloroquine amid controversy

 

The U.S. Food and Drug Administration has authorized hydroxychloroquine for emergency use for the treatment of patients with COVID-19 infection. Efficacy of the drug for COVID-19 is supported by anecdotal evidence and Donald Trump, but the approval is considered controversial. Novartis/Sandoz has donated 30 million doses and Bayer has donated 1 million tablets of chloroquine phosphate. Read More